Illumina has signed deals to genotype the sample collections at four biobanks. Each of the projects is aiming to build a repository of linked genotypic and phenotypic data, with the sequencing results generated by Illumina being paired to electronic medical records (EMRs) possessed by the owners of the biobanks.
Scientists at The Children's Hospital of Philadelphia (CHOP) and the Dana Farber Cancer Institute have uncovered an important cancer-driving fusion protein that promotes a pediatric brain tumor via three distinct mechanisms.
AstraZeneca has outlined how it is using the white-hot CRISPR genome editing technology to put its repositories of sequencing data to work in its R&D programs. The initiative is one of the many ways in which AstraZeneca is applying the technology at its drug discovery and development units.
DNAnexus has connected its genomics platform to Sapio Sciences' Exemplar laboratory information management system (LIMS). The integration is expected to provide clients with a sample-to-answer tracking system, a resource the collaborators see cutting costs while improving quality control.
Takeda has enlisted Broad Institute Genomic Services to analyze samples taken from patients who participated in a Phase III trial of its recently approved multiple myeloma drug, Ninlaro.
Illumina has outlined its plan to release a semiconductor-based sequencing system. The product, currently dubbed Firefly, will become the first Illumina sequencing system to rely on something other than optical readouts.
Leaders at NIH's genomics research wing are planning to funnel $240 million into the Centers for Common Disease Genomics, a newly created group focused on identifying the genetic factors involved in widespread health issues such as heart disease, diabetes, stroke and autism.
Sanofi has enlisted Global Genomics Group (G3) to help its hunt for the next generation of targets for cardiovascular diseases. The deal gives Sanofi access to data from a 7,500-person study run by G3, plus bioinformatics capabilities the genomics player has built to sift through the results.
A team at St. Jude Children's Research Hospital has created a tool to visualize the mutations that lead to pediatric cancers. The free application, called ProteinPaint, displays genetic lesions such as sequence mutations and gene fusion alongside RNA expression.
The Centers for Disease Control and Prevention (CDC) has hooked up with microbiome sequencing startup uBiome to study hospital-associated infections. At the heart of the collaboration is a major data generation and analysis initiative, for which uBiome will sequence 10,000 stool samples before sifting through the data to learn how the makeup of gut bacteria changes during hospital stays.